110 related articles for article (PubMed ID: 33290779)
21. The influence of physical activity in the anti-tumor immune response in experimental breast tumor.
Bianco TM; Abdalla DR; Desidério CS; Thys S; Simoens C; Bogers JP; Murta EFC; Michelin MA
Immunol Lett; 2017 Oct; 190():148-158. PubMed ID: 28818640
[TBL] [Abstract][Full Text] [Related]
22. Multifunctional T Lymphocytes Generated After Therapy With an Antitumor Gallotanin-Rich Normalized Fraction Are Related to Primary Tumor Size Reduction in a Breast Cancer Model.
Urueña C; Gomez A; Sandoval T; Hernandez J; Li S; Barreto A; Fiorentino S
Integr Cancer Ther; 2015 Sep; 14(5):468-83. PubMed ID: 26220604
[TBL] [Abstract][Full Text] [Related]
23. Immunotherapeutic vitamin E nanoemulsion synergies the antiproliferative activity of paclitaxel in breast cancer cells via modulating Th1 and Th2 immune response.
Pawar VK; Panchal SB; Singh Y; Meher JG; Sharma K; Singh P; Bora HK; Singh A; Datta D; Chourasia MK
J Control Release; 2014 Dec; 196():295-306. PubMed ID: 25459427
[TBL] [Abstract][Full Text] [Related]
24. PEG-derivatized octacosanol as micellar carrier for paclitaxel delivery.
Chu B; Qu Y; Huang Y; Zhang L; Chen X; Long C; He Y; Ou C; Qian Z
Int J Pharm; 2016 Mar; 500(1-2):345-59. PubMed ID: 26794876
[TBL] [Abstract][Full Text] [Related]
25. Ranitidine Inhibition of Breast Tumor Growth Is B Cell Dependent and Associated With an Enhanced Antitumor Antibody Response.
Rogers D; Vila-Leahey A; Pessôa AC; Oldford S; Marignani PA; Marshall JS
Front Immunol; 2018; 9():1894. PubMed ID: 30158936
[TBL] [Abstract][Full Text] [Related]
26. High Bak Expression Is Associated with a Favorable Prognosis in Breast Cancer and Sensitizes Breast Cancer Cells to Paclitaxel.
Luo Y; Wang X; Wang H; Xu Y; Wen Q; Fan S; Zhao R; Jiang S; Yang J; Liu Y; Li X; Xiong W; Ma J; Peng S; Zeng Z; Li X; Phillips JB; Li G; Tan M; Zhou M
PLoS One; 2015; 10(9):e0138955. PubMed ID: 26406239
[TBL] [Abstract][Full Text] [Related]
27. Enhanced paclitaxel cytotoxicity and prolonged animal survival rate by a nonviral-mediated systemic delivery of E1A gene in orthotopic xenograft human breast cancer.
Liao Y; Zou YY; Xia WY; Hung MC
Cancer Gene Ther; 2004 Sep; 11(9):594-602. PubMed ID: 15272313
[TBL] [Abstract][Full Text] [Related]
28. Taxol induced apoptosis regulates amino acid transport in breast cancer cells.
Wu Y; Shen D; Chen Z; Clayton S; Vadgama JV
Apoptosis; 2007 Mar; 12(3):593-612. PubMed ID: 17195090
[TBL] [Abstract][Full Text] [Related]
29. Maitake beta-glucan enhances therapeutic effect and reduces myelosupression and nephrotoxicity of cisplatin in mice.
Masuda Y; Inoue M; Miyata A; Mizuno S; Nanba H
Int Immunopharmacol; 2009 May; 9(5):620-6. PubMed ID: 19249389
[TBL] [Abstract][Full Text] [Related]
30. Recombinant virus-like particles presenting IL-33 successfully modify the tumor microenvironment and facilitate antitumor immunity in a model of breast cancer.
Feng X; Liu H; Chu X; Sun P; Huang W; Liu C; Yang X; Sun W; Bai H; Ma Y
Acta Biomater; 2019 Dec; 100():316-325. PubMed ID: 31542504
[TBL] [Abstract][Full Text] [Related]
31. Melittin-MIL-2 fusion protein as a candidate for cancer immunotherapy.
Liu M; Wang H; Liu L; Wang B; Sun G
J Transl Med; 2016 Jun; 14(1):155. PubMed ID: 27246873
[TBL] [Abstract][Full Text] [Related]
32. Soluble factor from murine bladder tumor-2 cell elevates nitric oxide production in macrophages and enhances the taxol-mediated macrophage cytotoxicity on tumor cells.
Choi SC; Oh HM; Park JS; Han WC; Yoon KH; Kim TH; Yun KJ; Kim EC; Nah YH; Cha YN; Chung HT; Jun CD
Cancer Invest; 2003; 21(5):708-19. PubMed ID: 14628429
[TBL] [Abstract][Full Text] [Related]
33. Paclitaxel enhances macrophage IL-12 production in tumor-bearing hosts through nitric oxide.
Mullins DW; Burger CJ; Elgert KD
J Immunol; 1999 Jun; 162(11):6811-8. PubMed ID: 10352302
[TBL] [Abstract][Full Text] [Related]
34. Enhanced sensitization to taxol-induced apoptosis by herceptin pretreatment in ErbB2-overexpressing breast cancer cells.
Lee S; Yang W; Lan KH; Sellappan S; Klos K; Hortobagyi G; Hung MC; Yu D
Cancer Res; 2002 Oct; 62(20):5703-10. PubMed ID: 12384528
[TBL] [Abstract][Full Text] [Related]
35. Taxol provides a second signal for murine macrophage tumoricidal activity.
Manthey CL; Perera PY; Salkowski CA; Vogel SN
J Immunol; 1994 Jan; 152(2):825-31. PubMed ID: 7506736
[TBL] [Abstract][Full Text] [Related]
36. Investigation of the antitumor activity and toxicity of long-circulating and fusogenic liposomes co-encapsulating paclitaxel and doxorubicin in a murine breast cancer animal model.
Franco MS; Roque MC; de Barros ALB; de Oliveira Silva J; Cassali GD; Oliveira MC
Biomed Pharmacother; 2019 Jan; 109():1728-1739. PubMed ID: 30551427
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-12 activated CD8
Yang SX; Wei WS; Ouyan QW; Jiang QH; Zou YF; Qu W; Tu JH; Zhou ZB; Ding HL; Xie CW; Lei QM; Zhong CR
Biomed Pharmacother; 2016 Dec; 84():1466-1471. PubMed ID: 27810342
[TBL] [Abstract][Full Text] [Related]
38. Influence of the phosphodiesterase-5 inhibitor, sildenafil, on sensitivity to chemotherapy in breast tumor cells.
Di X; Gennings C; Bear HD; Graham LJ; Sheth CM; White KL; Gewirtz DA
Breast Cancer Res Treat; 2010 Nov; 124(2):349-60. PubMed ID: 20155316
[TBL] [Abstract][Full Text] [Related]
39. Arteether exerts antitumor activity and reduces CD4+CD25+FOXP3+ T-reg cells in vivo.
Azimi Mohamadabadi M; Hassan ZM; Zavaran Hosseini A; Gholamzad M; Noori S; Mahdavi M; Maroof H
Iran J Immunol; 2013 Sep; 10(3):139-49. PubMed ID: 24076591
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-21 enhances NK cell activation in response to antibody-coated targets.
Roda JM; Parihar R; Lehman A; Mani A; Tridandapani S; Carson WE
J Immunol; 2006 Jul; 177(1):120-9. PubMed ID: 16785506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]